Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Medical Genetics

Welcome to the SMS Community: An Orientation for Parents and Caregivers

At a Glance

Smith-Magenis syndrome is a rare genetic neurodevelopmental disorder usually caused by a 17p11.2 deletion involving RAI1 or a disease-causing RAI1 variant. Early intervention, sleep support, and coordinated care can help children reach their potential.

Receiving a diagnosis of Smith-Magenis Syndrome (SMS) can feel like a whirlwind of emotions. For many parents, the initial reaction is a mix of grief for the path they imagined and relief at finally having a name for the challenges their child has been facing [1]. It is completely normal to feel overwhelmed, but please know that you are not alone on this journey. SMS is a multisystem neurodevelopmental disorder, meaning it affects many different parts of the body and how the brain develops [2]. While the road ahead will require lifelong support, children with SMS are known for their vibrant personalities and can lead full, meaningful lives [3].

Why This Diagnosis May Have Taken Time

If your local doctors seemed unfamiliar with SMS, there is a clear reason: it is a rare condition. The most widely accepted estimate is that SMS occurs in approximately 1 in 25,000 births [4][5]. Because it is so rare, many pediatricians may never have seen a case in their entire career. This rarity often leads to a “diagnostic odyssey,” where families spend years searching for answers before a genetic test confirms the diagnosis [6][7].

Understanding the Genetic Cause

SMS is a genetic condition. In the vast majority of cases, it occurs “de novo,” which means it happened by chance at the time of conception [8]. However, in rare instances, a chromosomal deletion can be inherited through a parental balanced rearrangement, or an RAI1 variant can be inherited in an autosomal-dominant pattern. Because of this, parental genetic testing and formal genetic counseling are strongly recommended to determine your family’s exact recurrence risk.

Most cases (about 90%) are caused by a small missing piece (deletion) of chromosome 17, specifically at a location called 17p11.2 [2][9]. This missing piece includes a critical gene called RAI1. The remaining 10% of cases are caused by a tiny spelling error (pathogenic variant) within the RAI1 gene itself [10].

Early Signs in Infancy

Looking back, you may recognize certain signs that were present even in the first few months of your child’s life. While every child is different, common early features include:

  • Hypotonia: Low muscle tone, often described as a baby feeling “floppy” [11].
  • Feeding Difficulties: Many infants have trouble sucking or swallowing, which can lead to poor weight gain [11][12].
  • Developmental Delays: Reaching milestones like sitting up, crawling, or babbling typically happens later than expected [13][14].
  • Distinctive Facial Features: Doctors may notice subtle physical traits, such as a broad forehead, a tented upper lip (shaped like a small ‘V’), or deep-set eyes [15].

(Note: Some retrospective reports describe infants with SMS as exceptionally “quiet” or rarely crying to be fed. Never normalize these symptoms. A baby who is difficult to wake, feeds poorly, or has breathing difficulties needs prompt medical assessment, regardless of their diagnosis.)

Hallmark Features: Sleep and Behavior

As children grow, two hallmark features of SMS usually become more apparent: a unique sleep pattern and specific behavioral challenges.

  • Inverted Sleep Rhythm: Many individuals with SMS have a “flipped” melatonin cycle, making them very sleepy during the day and wide awake at night [16][14]. This sleep fragmentation can be one of the most exhausting aspects for caregivers [17].
  • Behavioral Patterns: Children with SMS often have a “charming” and social side, but they may also experience intense meltdowns, impulsivity, or self-hugging [1][18]. These behaviors are part of the syndrome and are often linked to communication frustrations and sleep deprivation [19].

Looking Toward the Future

SMS is a lifelong journey that requires a team of specialists to manage various medical and developmental needs. While people with SMS will likely need some level of support throughout their lives, many reach adulthood and find ways to contribute to their communities [20][18]. Current research emphasizes that early intervention is vital for helping children reach their full potential [13].

Common questions in this guide

What causes Smith-Magenis syndrome?
About 90% of cases are caused by a missing piece of chromosome 17 at 17p11.2 that includes the RAI1 gene. Most cases happen as a new change at conception; about 10% result from a disease-causing change within RAI1 itself.
What are the early signs of Smith-Magenis syndrome?
Early signs can include low muscle tone, feeding or swallowing difficulties, poor weight gain, delayed milestones, and distinctive facial features such as a broad forehead, tented upper lip, or deep-set eyes. These findings vary, and a baby who is difficult to wake, feeds poorly, or has breathing problems needs prompt medical assessment.
Why does Smith-Magenis syndrome affect sleep?
Many people with Smith-Magenis syndrome have an inverted sleep rhythm, with sleepiness during the day and wakefulness at night. Fragmented sleep can be exhausting for families, so ask the care team whether a sleep evaluation or sleep specialist is appropriate.
What support and therapies can help a child with Smith-Magenis syndrome?
Early intervention may include physical, occupational, and speech therapy based on a child's needs. Ongoing coordination among specialists and therapists can help address medical, developmental, sleep, communication, and behavioral needs.
Should parents have genetic testing after a child is diagnosed with SMS?
Yes, parental genetic testing and formal genetic counseling are strongly recommended because most cases are new changes, but rare cases involve an inherited chromosome rearrangement or RAI1 variant. Testing can help clarify the family's recurrence risk and guide counseling.
What medical screenings should be discussed after an SMS diagnosis?
Ask your child's healthcare team about screening for hearing loss, vision problems, and heart concerns, as well as an evaluation of sleep when indicated. The specific schedule and tests should be tailored to your child's findings and care needs.
Can children with Smith-Magenis syndrome lead meaningful lives?
Smith-Magenis syndrome is lifelong, and many people need some level of support throughout life. Many reach adulthood and find ways to contribute to their communities, while early intervention can help children develop their potential.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Smith-Magenis syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was the specific genetic result for my child, and what does it tell us about the condition?
  2. 2.Has my child been screened for common medical associations like hearing loss, vision issues, or heart concerns?
  3. 3.What specific early intervention services (such as physical, occupational, or speech therapy) are most appropriate for my child right now?
  4. 4.Can you help us coordinate a sleep study or connect us with a specialist who understands the unique sleep-wake patterns of SMS?
  5. 5.Are there local specialists or a regional center of excellence with specific experience in managing rare genetic disorders?

References

References (20)
  1. 1

    Parental experiences with behavioural problems in Smith-Magenis syndrome: The need for syndrome-specific competence.

    Nag HE, Hoxmark LB, Nærland T

    Journal of intellectual disabilities : JOID 2019; (23(3)):359-372 doi:10.1177/1744629519847375.

    PMID: 31046579
  2. 2

    Smith-Magenis Syndrome-Clinical Review, Biological Background and Related Disorders.

    Rinaldi B, Villa R, Sironi A, et al.

    Genes 2022; (13(2)) doi:10.3390/genes13020335.

    PMID: 35205380
  3. 3

    A Clinical Practice Example of Smith-Magenis Syndrome in the Neuropediatric Clinic: Etiology, Clinical Presentation, Diagnostics and Therapeutic Approaches-A Case Report.

    Shevchenko O

    Children (Basel, Switzerland) 2026; (13(2)) doi:10.3390/children13020179.

    PMID: 41749535
  4. 4

    Prenatal diagnosis and neonatal phenotype of a de novo microdeletion of 17p11.2p12 associated with Smith-Magenis syndrome and external genital defects.

    Zhang P, Sun Y, Tian H, et al.

    Journal of genetics 2020; (99()).

    PMID: 32661203
  5. 5

    Generation of the CSSi020-A (14437) iPSC line from a patient carrying a copy number variation (CNV) in the 17p11.2 chromosome region.

    Giovenale AMG, Turco EM, Mazzoni M, et al.

    Stem cell research 2024; (81()):103544 doi:10.1016/j.scr.2024.103544.

    PMID: 39260069
  6. 6

    From Behavioral and Sleep Disturbances to Genetic Diagnosis: Smith-Magenis Syndrome and the Importance of the Diagnostic Pathway.

    Kılıçaslan F, Çetin ARO, Öz Ö, et al.

    Developmental neurobiology 2026; (86(3)):e70051 doi:10.1002/dneu.70051.

    PMID: 42396610
  7. 7

    Delayed diagnosis in a house of correction: Smith-Magenis syndrome due to a de novo nonsense RAI1 variant.

    Yeetong P, Vilboux T, Ciccone C, et al.

    American journal of medical genetics. Part A 2016; (170(9)):2383-8 doi:10.1002/ajmg.a.37602.

    PMID: 27311559
  8. 8

    Prenatal Diagnosis of 17p11.2 Copy Number Abnormalities Associated With Smith-Magenis and Potocki-Lupski Syndromes in Fetuses.

    Cai M, Fu X, Xu L, et al.

    Frontiers in genetics 2021; (12()):779237 doi:10.3389/fgene.2021.779237.

    PMID: 34992630
  9. 9

    Generation and characterization of the CSSi021-A (15665) human induced pluripotent stem cell line from a Smith-Magenis syndrome patient with a heterozygous RAI1 mutation.

    Giovenale AMG, Turco EM, Ferrone I, et al.

    Stem cell research 2025; (86()):103726 doi:10.1016/j.scr.2025.103726.

    PMID: 40311325
  10. 10

    Deletion of RAI1 noncoding exons 1-2 causes Smith-Magenis syndrome.

    Hamiel U, Kurolap A, Gadot CC, et al.

    Journal of genetics 2025; (104()).

    PMID: 40386916
  11. 11

    First Case Report of Smith-Magenis Syndrome (SMS) Among the Arab Community in Nazareth: View and Overview.

    Nijim Y, Adawi A, Bisharat B, Bowirrat A

    Medicine 2016; (95(3)):e2362 doi:10.1097/MD.0000000000002362.

    PMID: 26817868
  12. 12

    Smith-Magenis syndrome with Dandy-Walker malformation in a 2-year-old girl: A case report.

    Zhu WT, Jiang LX, Ma YM, et al.

    The Journal of international medical research 2025; (53(1)):3000605241310844 doi:10.1177/03000605241310844.

    PMID: 39797380
  13. 13

    Smith-Magenis syndrome: Clinical and behavioral characteristics in a large retrospective cohort.

    Rive Le Gouard N, Jacquinet A, Ruaud L, et al.

    Clinical genetics 2021; (99(4)):519-528 doi:10.1111/cge.13906.

    PMID: 33368193
  14. 14

    Adrenocorticotropic Hormone Therapy Improved Spasms and Sleep Disturbance in Smith-Magenis Syndrome: A Case Report.

    Momosaki K, Kido J, Matsumoto S, et al.

    Pediatric reports 2020; (12(3)):72-76 doi:10.3390/pediatric12030018.

    PMID: 33114276
  15. 15

    Smith-Magenis Syndrome: Face Speaks.

    Gupta R, Gupta N, Nampoothiri S, et al.

    Indian journal of pediatrics 2016; (83(6)):589-93 doi:10.1007/s12098-015-1940-y.

    PMID: 26676648
  16. 16

    A cross-syndrome cohort comparison of sleep disturbance in children with Smith-Magenis syndrome, Angelman syndrome, autism spectrum disorder and tuberous sclerosis complex.

    Trickett J, Heald M, Oliver C, Richards C

    Journal of neurodevelopmental disorders 2018; (10(1)):9 doi:10.1186/s11689-018-9226-0.

    PMID: 29490614
  17. 17

    Caregivers' experience of sleep management in Smith-Magenis syndrome: a mixed-methods study.

    Agar G, Bissell S, Wilde L, et al.

    Orphanet journal of rare diseases 2022; (17(1)):35 doi:10.1186/s13023-021-02159-8.

    PMID: 35120534
  18. 18

    Psychiatric and neurological manifestations in adults with Smith-Magenis syndrome: A scoping review.

    Korteling D, Musch JLI, Zinkstok JR, Boot E

    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2024; (195(2)):e32956 doi:10.1002/ajmg.b.32956.

    PMID: 37584268
  19. 19

    Management of Sleep Disturbances Associated with Smith-Magenis Syndrome.

    Kaplan KA, Elsea SH, Potocki L

    CNS drugs 2020; (34(7)):723-730 doi:10.1007/s40263-020-00733-5.

    PMID: 32495322
  20. 20

    Bilateral renal tumors in an adult man with Smith-Magenis syndrome: The role of the FLCN gene.

    Dardour L, Verleyen P, Lesage K, et al.

    European journal of medical genetics 2016; (59(10)):499-501.

    PMID: 27633572

This page is for informational purposes only and does not replace professional medical advice about Smith-Magenis syndrome. Your child's geneticist and care team can interpret the diagnosis and recommend individualized screenings, sleep evaluation, and therapies.